• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Cervical Cancer Elimination Is Dependent on Women's Self-Tests for Primary Human Papillomavirus Testing Triaged by Methylation Status.宫颈癌消除依赖于通过甲基化状态分类的女性原发性人乳头瘤病毒检测的自我检测。
J Clin Oncol. 2022 Sep 10;40(26):3003-3005. doi: 10.1200/JCO.22.00609. Epub 2022 May 20.
2
Cervical cancer prevention: Human papillomavirus testing as primary screening.宫颈癌预防：人乳头瘤病毒检测作为初筛。
Cancer. 2022 Mar 1;128(5):939-943. doi: 10.1002/cncr.34006. Epub 2021 Nov 12.
3
Primary HPV and Molecular Cervical Cancer Screening in US Women Living With Human Immunodeficiency Virus.美国感染人类免疫缺陷病毒女性的原发性人乳头瘤病毒及分子宫颈癌筛查
Clin Infect Dis. 2021 May 4;72(9):1529-1537. doi: 10.1093/cid/ciaa1317.
4
Human papillomavirus testing as a primary screening tool for cervical cancer.人乳头瘤病毒检测作为宫颈癌的主要筛查工具。
J Gynecol Oncol. 2021 May;32(3):e56. doi: 10.3802/jgo.2021.32.e56.
5
[Cervical cancer screning: from cytology to HPV testing].[宫颈癌筛查：从细胞学检查到HPV检测]
Zhonghua Fu Chan Ke Za Zhi. 2019 May 25;54(5):289-292. doi: 10.3760/cma.j.issn.0529-567x.2019.05.001.
6
Human papillomavirus (HPV) testing for cervical cancer screening in a middle-income country: comment on a large real-world implementation study in China.在中等收入国家进行人乳头瘤病毒（HPV）检测用于宫颈癌筛查：对中国一项大型真实世界实施研究的评论
BMC Med. 2021 Jul 15;19(1):165. doi: 10.1186/s12916-021-02051-z.
7
Re: Human papillomavirus testing in the prevention of cervical cancer.关于：人乳头瘤病毒检测在宫颈癌预防中的应用
J Natl Cancer Inst. 2011 Oct 5;103(19):1482-3; author reply 1483-4. doi: 10.1093/jnci/djr308. Epub 2011 Aug 22.
8
Is it time to introduce HPV self-sampling for primary cervical cancer screening?是时候引入人乳头瘤病毒（HPV）自我采样用于宫颈癌初筛了吗？
J Natl Cancer Inst. 2012 Feb 8;104(3):166-7. doi: 10.1093/jnci/djr544. Epub 2012 Jan 23.
9
Turkish and Moroccan Dutch women's views of using a self-sampling kit for human papillomavirus testing as a tool for cervical cancer screening: What are the barriers and the motivators?土耳其和摩洛哥荷兰裔女性对使用自我采样试剂盒进行人乳头瘤病毒检测作为宫颈癌筛查工具的看法：有哪些障碍和促进因素？
Womens Health (Lond). 2021 Jan-Dec;17:17455065211065873. doi: 10.1177/17455065211065873.
10
Should screening for cervical cancer go to primary human papillomavirus testing and eliminate cytology?是否应该将宫颈癌筛查转为基于人乳头瘤病毒（HPV）的初筛并淘汰细胞学检查？
Mod Pathol. 2022 Jul;35(7):858-864. doi: 10.1038/s41379-022-01052-4. Epub 2022 Mar 7.

引用本文的文献

1
Comparison of mutations in myelodysplasia and acute leukemia suggests divergent roles in initiation and progression.骨髓发育异常和急性白血病中突变的比较表明，它们在起始和进展过程中发挥着不同的作用。
Blood Neoplasia. 2024 Feb 15;1(1):100004. doi: 10.1016/j.bneo.2024.100004. eCollection 2024 Mar.
2
Effect of HPV integration on prognosis of young women with CIN2 in China: protocol for a multicentre prospective cohort study.人乳头瘤病毒整合对中国CIN2年轻女性预后的影响：一项多中心前瞻性队列研究方案
BMJ Open. 2025 Apr 28;15(4):e093863. doi: 10.1136/bmjopen-2024-093863.
3
Oncogenic and teratogenic effects of , an inflammation-prone mouse model of the human hotspot mutant .人类热点突变体的一种易发生炎症的小鼠模型的致癌和致畸作用。 （备注：原文中“Oncogenic and teratogenic effects of ”后面缺少具体内容，翻译只能根据现有内容尽量准确表述）
Elife. 2025 Apr 14;13:RP102434. doi: 10.7554/eLife.102434.
4
Tumor suppressor genes in the tumor microenvironment.肿瘤微环境中的肿瘤抑制基因。
Dis Model Mech. 2025 Mar 1;18(3). doi: 10.1242/dmm.052049. Epub 2025 Mar 20.
5
Performance of DNA methylation analysis in the detection of high-grade cervical intraepithelial neoplasia or worse (CIN3+): a cross-sectional study.DNA甲基化分析在检测高级别宫颈上皮内瘤变或更严重病变（CIN3+）中的性能：一项横断面研究
Infect Agent Cancer. 2023 Nov 29;18(1):77. doi: 10.1186/s13027-023-00555-2.
6
Te Ara Waiora-Implementing human papillomavirus (HPV) primary testing to prevent cervical cancer in Aotearoa New Zealand: A protocol for a non-inferiority trial.《在新西兰实施人乳头瘤病毒（HPV）初筛以预防宫颈癌：一项非劣效性试验方案》。
PLoS One. 2023 Mar 23;18(3):e0280643. doi: 10.1371/journal.pone.0280643. eCollection 2023.
7
Cervical Cancer Stage at Diagnosis and Survival among Women ≥65 Years in California.加利福尼亚州≥65 岁女性诊断时的宫颈癌分期和生存情况。
Cancer Epidemiol Biomarkers Prev. 2023 Jan 9;32(1):91-97. doi: 10.1158/1055-9965.EPI-22-0793.

本文引用的文献

1
Clinical Regression of High-Grade Cervical Intraepithelial Neoplasia Is Associated With Absence of DNA Methylation (CONCERVE Study).高级别宫颈上皮内瘤变的临床消退与 DNA 甲基化缺失相关（CONCERVE 研究）。
J Clin Oncol. 2022 Sep 10;40(26):3037-3046. doi: 10.1200/JCO.21.02433. Epub 2022 May 5.
2
Maternal HPV-antibodies and seroconversion to HPV in children during the first 3 years of life.母亲 HPV 抗体及儿童在生命最初 3 年内 HPV 血清转化。
Sci Rep. 2022 Feb 9;12(1):2227. doi: 10.1038/s41598-022-06343-z.
3
Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study.荷兰常规初级HPV筛查中高危型HPV自我采样与临床医生采样的临床性能：一项观察性研究。
Lancet Reg Health Eur. 2021 Nov 9;11:100235. doi: 10.1016/j.lanepe.2021.100235. eCollection 2021 Dec.
4
Worldwide use of HPV self-sampling for cervical cancer screening.全球范围内使用 HPV 自我采样进行宫颈癌筛查。
Prev Med. 2022 Jan;154:106900. doi: 10.1016/j.ypmed.2021.106900. Epub 2021 Nov 30.
5
Clinical follow-up practices after cervical cancer screening by co-testing: A population-based study of adherence to U.S. guideline recommendations.人乳头瘤病毒联合检测后宫颈癌筛查的临床随诊实践：一项基于人群的美国指南推荐依从性研究。
Prev Med. 2021 Dec;153:106770. doi: 10.1016/j.ypmed.2021.106770. Epub 2021 Aug 18.
6
Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials.二价或四价 HPV 疫苗诱导的中和抗体的持久性及其与疗效的相关性：两项随机、双盲、多中心、III 期临床试验数据的联合随访分析。
Lancet Infect Dis. 2021 Oct;21(10):1458-1468. doi: 10.1016/S1473-3099(20)30873-2. Epub 2021 May 31.
7
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.普通风险人群的宫颈癌筛查：美国癌症协会 2020 年指南更新。
CA Cancer J Clin. 2020 Sep;70(5):321-346. doi: 10.3322/caac.21628. Epub 2020 Jul 30.
8
Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines.支持 2019 ASCCP 基于风险的管理共识指南的风险估计。
J Low Genit Tract Dis. 2020 Apr;24(2):132-143. doi: 10.1097/LGT.0000000000000529.
9
Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework.BD Onclarity HPV 检测在丹麦宫颈筛查项目中使用 SurePath 筛查样本的临床和分析性能，采用 VALGENT 框架。
J Clin Microbiol. 2020 Jan 28;58(2). doi: 10.1128/JCM.01518-19.
10
Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans.欧洲基于 HPV 的宫颈癌初筛：实施现状、挑战与未来计划。
Clin Microbiol Infect. 2020 May;26(5):579-583. doi: 10.1016/j.cmi.2019.09.006. Epub 2019 Sep 17.

Cervical Cancer Elimination Is Dependent on Women's Self-Tests for Primary Human Papillomavirus Testing Triaged by Methylation Status.

作者信息

Harper Diane M

机构信息

University of Michigan, Michigan Institute of Clinical and Health Research, Departments of Family Medicine, Obstetrics and Gynecology, Women's and Gender Studies, Ann Arbor, MI.

出版信息

J Clin Oncol. 2022 Sep 10;40(26):3003-3005. doi: 10.1200/JCO.22.00609. Epub 2022 May 20.

DOI:10.1200/JCO.22.00609
PMID:35594490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9470128/
Abstract
摘要